Japan Circulating Tumor Cells Market Size & Outlook
Related Markets
Japan circulating tumor cells market highlights
- The Japan circulating tumor cells market generated a revenue of USD 727.5 million in 2025 and is expected to reach USD 2,047.8 million by 2033.
- The Japan market is expected to grow at a CAGR of 14% from 2026 to 2033.
- In terms of segment, ctc detection & enrichment methods was the largest revenue generating technology in 2025.
- CTC Analysis is the most lucrative technology segment registering the fastest growth during the forecast period.
Circulating tumor cells market data book summary
| Market revenue in 2025 | USD 727.5 million |
| Market revenue in 2033 | USD 2,047.8 million |
| Growth rate | 14% (CAGR from 2026 to 2033) |
| Largest segment | Ctc detection & enrichment methods |
| Fastest growing segment | CTC Analysis |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis |
| Key market players worldwide | Qiagen NV, Bio-Techne Corp, Praxis Precision Medicines Inc Ordinary Shares, Aviva PLC, Biocept Inc, Neurocrine Biosciences Inc, Greiner Bio-One, Miltenyi Biotec, Icon PLC, Ecolab Inc, Arcus Biosciences Inc, Epic Corp, Screen Holdings Co Ltd, Menarini Group, Vtex Ordinary Shares - Class A, Sysmex Corp, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, Japan accounted for 5.2% of the global circulating tumor cells market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China circulating tumor cells market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,457.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Circulating Tumor Cells Market Scope
Circulating Tumor Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Vtex Ordinary Shares - Class A | View profile | 1277 | 125 Kingsway, Aviation House, London, United Kingdom, WC2B 6NH | https://www.vtex.com |
| Arcus Biosciences Inc | View profile | 577 | 3928 Point Eden Way, Hayward, CA, United States, 94545 | https://www.arcusbio.com |
| Neurocrine Biosciences Inc | View profile | 1448 | 12780 El Camino Real, San Diego, CA, United States, 92130 | https://www.neurocrine.com |
| Praxis Precision Medicines Inc Ordinary Shares | View profile | 82 | 99 High Street, 30th Floor, Boston, MA, United States, 02110 | https://www.praxismedicines.com |
| STEMCELL Technologies | View profile | 501-1000 | Vancouver, British Columbia, Canada, North America | https://www.stemcell.com |
| Menarini Group | View profile | 1001-5000 | Firenze, Toscana, Italy, Europe | http://www.menarini.com |
| Greiner Bio-One | View profile | 1001-5000 | Monroe, North Carolina, United States, North America | https://www.gbo.com/en_US/ |
| Ecolab Inc | View profile | 48000 | 1 Ecolab Place, Saint Paul, MN, United States, 55102 | https://www.ecolab.com |
| Aviva PLC | View profile | 23247 | St Helen's, 1 Undershaft, London, United Kingdom, EC3P 3DQ | https://www.aviva.com |
| Screen Holdings Co Ltd | View profile | 6589 | Tenjinkita-machi 1-1, Teranouchi-agaru, 4-chome, Horikawa-dori, Kamigyo-ku, Kyoto, Japan, 602-8585 | https://www.screen.co.jp |
| Miltenyi Biotec | View profile | 1001-5000 | Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europe | http://www.miltenyibiotec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Biocept Inc | View profile | 50 | 9955 Mesa Rim Road, San Diego, CA, United States, 92121 | https://www.biocept.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Epic Corp | View profile | 2 | PO Box 11147, Newport Beach, CA, United States, 92658 |
Japan circulating tumor cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.
Ctc detection & enrichment methods was the largest segment with a revenue share of 56.8% in 2025. Horizon Databook has segmented the Japan circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2021 to 2033.
Japan is one of the largest manufacturers of generic pharmaceuticals, which represents the world’s eighth largest market in terms of value. The growing geriatric population has increased the medical expenditure in the country. To reduce the healthcare expenses, a cabinet decision was passed in 2015 with an aim to achieve generic drugs share of around 80% by September 2020.
Due to the government efforts for higher use of generics, certain players are expanding their geographical presence and focusing on export of Japanese quality standard products back to their country to gain considerable profit margin.
Moreover, the drug pricing policy of the country is attractive for generic manufacturers, helping them establish their presence in the market. The National Health Insurance System in Japan sets the reimbursement price of generic drugs and biosimilar at 50% or less & 70%, respectively, than the originator drug.
Reasons to subscribe to Japan circulating tumor cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan circulating tumor cells market databook
-
Our clientele includes a mix of circulating tumor cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan circulating tumor cells market , including forecasts for subscribers. This country databook contains high-level insights into Japan circulating tumor cells market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Japan circulating tumor cells market size, by technology, 2021-2033 (US$M)
Japan Circulating Tumor Cells Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
